Neoadjuvant LDRT Combined With Durvalumab in Potentially Resectable Stage III NSCLC
Clinical trial NCT05157542 · UNKNOWN
Trial details
- NCT number
- NCT05157542
- Sponsor
- Juan LI, MD
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-10
- Primary completion
- 2023-06-10
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.